Combination of doses, better than monotherapy for pulmonary hypertension

Published Date: 08 Mar 2023

People with hypertension (high blood pressure in the arteries that supply the lungs, also known as PAH) have up to a two-fold reduction in pulmonary vascular resistance (PVR) when taking PAH.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

In Relapsed/Refractory Myeloma, Blenrep-Based Regimen Produces PFS Advantage.

2.

Scientists call into question safety of potential new anticancer treatment

3.

The American College of Physicians updated its recommendations for colorectal cancer screening.

4.

Tafasitamab-Based Combination Boosts PFS in Relapsed/Refractory Follicular Lymphoma

5.

Preoperative Embolization Linked to Relapse-Free Survival in Meningioma


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot